Dagadas, Hasmera P.

HRN: 24-95-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2024
CEFUROXIME 1.5GM (VIAL)
05/10/2024
05/17/2024
IVT
1.5gms
On Call To OR Then Q 8 Hrs
Repeat LTCS
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: